Glimepiride Tablet
Product Images NDC 43063-699

3 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 43063-699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063699)

Image (43063699)
Label for Glimepiride 4 mg tablets USP, oral dosage form, containing 180 tablets. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Carlsbad Technology, Inc., Carlsbad, CA. The label includes storage instructions, dosage notice, a barcode, and a QR code with GTIN, lot number, and expiration date 10/2021. "Rx Only" is prominently displayed.*
FDA Label Image

Figure (Gli00 0001 03)

Figure (Gli00 0001 03)
Glimepiride 4 mg oral tablet blister pack. The white tablet is embossed with 'C 117' on one side. This product is from PD-Rx Pharmaceuticals, Inc. and has a product NDC of 43063-699.*
FDA Label Image

Structural Formula (Gli00 0001 04)

Structural Formula (Gli00 0001 04)
Chemical structure of Glimepiride, illustrating its specific molecular arrangement as provided in the product data for this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.